It is especially useful for skin with visible dark spots, uneven tone, photoageing, lack of radiance or the need for intensive antioxidant support within combined treatments
Substance P, NPY, CCK and their receptors in five brain regions in major depressive disorder with transcriptomic analysis of locus coeruleus neurons
Cardiovascular Risk Reduction: With the 2023 approval for reducing major adverse cardiovascular events, GLP-1 receptor agonists are now used within comprehensive cardiovascular risk-management strategies for patients with type 2 diabetes and established cardiovascular disease
Melanotan II: a possible cause of renal infarction: review of the literature and case report
However, it never received FDA approval because the results, while positive, weren't dramatic enough to meet regulatory thresholds for an obesity drug
J Hazard Mater 502:140998